Mangalam Drugs And Organics Limited has submitted to the Exchange, the financial results for the period ended December 31, 2025.
MANGALAM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Mangalam Drugs And Organics Limited has filed its financial results with NSE for the period ending December 31, 2025, likely covering the third quarter of FY26. This is a routine stock exchange compliance submission. No specific financial figures, segment data, or auditor commentary are included in this brief notice. Investors will need to review the full results document for actual performance details.
Neutral announcement in isolation — this only confirms timely filing of results. The actual numbers, margin trends, and any auditor remarks in the detailed filing will determine whether the stock reacts positively or negatively.